Xeris Biopharma Holdings, Inc. (XERS)
9.08
-0.17
(-1.84%)
USD |
NASDAQ |
Oct 02, 16:00
9.085
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings EPS Diluted (Quarterly) : -0.18 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.18 |
| March 31, 2026 | 0.0126 |
| December 31, 2025 | 0.0615 |
| September 30, 2025 | 0.0035 |
| June 30, 2025 | -0.0121 |
| March 31, 2025 | -0.0605 |
| December 31, 2024 | -0.0343 |
| September 30, 2024 | -0.1056 |
| June 30, 2024 | -0.1012 |
| March 31, 2024 | -0.1351 |
| December 31, 2023 | -0.0969 |
| September 30, 2023 | -0.0883 |
| June 30, 2023 | -0.1445 |
| March 31, 2023 | -0.1228 |
| December 31, 2022 | -0.0951 |
| September 30, 2022 | -0.1606 |
| June 30, 2022 | -0.1932 |
| March 31, 2022 | -0.2497 |
| December 31, 2021 | -0.4179 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.3911 |
| June 30, 2021 | -0.4146 |
| March 31, 2021 | -0.3006 |
| December 31, 2020 | -0.4085 |
| September 30, 2020 | -0.3467 |
| June 30, 2020 | -0.6346 |
| March 31, 2020 | -0.89 |
| December 31, 2019 | -1.225 |
| September 30, 2019 | -1.219 |
| June 30, 2019 | -1.279 |
| March 31, 2019 | -1.073 |
| December 31, 2018 | -0.9829 |
| September 30, 2018 | -0.7129 |
| June 30, 2018 | -3.07 |
| March 31, 2018 | -0.5783 |
| December 31, 2017 | -0.4442 |
| September 30, 2017 | -0.3656 |
| June 30, 2017 | -0.2529 |
| March 31, 2017 | -0.2258 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Zevra Therapeutics, Inc. | 0.1368 |
| Aclaris Therapeutics, Inc. | -0.1507 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -31.10M |
| Revenue (Quarterly) | 92.10M |
| Total Expenses (Quarterly) | 123.20M |
| Enterprise Value | 1.744B |
| Gross Profit Margin (Quarterly) | 83.47% |
| Profit Margin (Quarterly) | -33.77% |
| Earnings Yield | -1.13% |
| Operating Earnings Yield | 2.28% |
| Normalized Earnings Yield | 0.2456 |